Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alba Bioscience

1998 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of monoclonal blood grouping reagents intended to supply vital products to hospitals, blood services and other diagnostic companies. The company's monoclonal blood grouping reagents are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease, enabling the hospitals to get a continous improvement of transfusion practiceand the ability to provide new diagnostic tests for changing health care needs, ultimately providing higher standards of patient care around the world.

Formerly Known As
Diagnostics Scotland
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Medical Supplies
Primary Office
  • 21 Ellen's Glen Road
  • Edinburgh EH17 7QT
  • Scotland

Alba Bioscience Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alba Bioscience‘s full profile, request access.

Request full access to PitchBook

Alba Bioscience Executive Team (1)

Name Title Board
Seat
Contact
Info
John Allan Chief Executive Officer